Patient-friendly peptide education
General peptide therapy, clinics, safety, brands and long-tail topics.
Recently published
Today, a brief rundown of news involving Replimune, Revolution Medicines and Merck KGaA, as well as updates from Eli Lilly, Otsuka Pharmaceutical and Definium Therapeutics that you may have missed. On Friday, …
Read guide →Peptides And Minoxidil Together Peptides And Minoxidil Together and Skin Barrier Regulation:Molecular Insights Sustained growth within this sector reshapes technical standards for raw peptide evaluation and qu…
Read guide →Dsip Simple Peptides Understanding Dsip Simple Peptides:Field Practice Summary Of Peptide Research Evolving consumer cognition reshapes how bioactive peptide raw materials are evaluated within modern technical…
Read guide →Peptides For Brain Trauma Cracking Peptides For Brain Trauma:Standard Evaluation Rules of Peptide Molecular Purity Precision engineering of amino acid side-chain protecting groups represents a cutting-edge fro…
Read guide →Peptide Chain Reaction Deciphering Peptide Chain Reaction:Bench Notes on Lyophilization Time Natural peptides carry mild biological characteristics and reliable bioactivity, gaining broad recognition among res…
Read guide →Medi Peel Peptide 9 Patch Uncovering The Research Potential Of Medi Peel Peptide 9 Patch:Future Exploration Directions Exploring the evolving peptide landscape reveals distinct trajectories for therapeutic ver…
Read guide →Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback . Today, a brief rundown of news involving Crinetics and the Food and Drug Administration, as well as updates f…
Read guide →Living with an autoimmune disease often means navigating a lifelong, complex condition. A recent study estimates that autoimmune diseases affect 400 to 600 million people worldwide, with the burden continuing …
Read guide →Arthrosi Therapeutics has secured a nine-figure funding round to accelerate development of a new kind of gout medicine. The San Diego-based biotechnology startup on Wednesday revealed it has closed $153 millio…
Read guide →Dive Brief: Evommune, a biotechnology company developing treatments for chronic inflammatory conditions, revealed plans to go public in a Thursday filing with the Securities and Exchange Commission. Evommune i…
Read guide →Anti Gout Peptide Anti Gout Peptide: Navigating Long-Term Laboratory Evaluation Regulatory expectations have driven the implementation of more rigorous production and quality assurance protocols. The cognition…
Read guide →This compelling four-part podcast series, “The Progress Profile: Alzheimer’s Research in Focus,” brings together world-renowned experts to explore the latest Alzheimer's breakthroughs. Dr. John Harrison leads …
Read guide →Today, a brief rundown of news from Iambic Therapeutics and Merck & Co., as well as updates from Roche, Lundbeck and Viridian Therapeutics that you may have missed. The AI-driven biotechnology company Iambic T…
Read guide →UniQure, the Netherlands-based gene therapy developer, lost more than 65% of its value Monday morning after disclosing that the Food and Drug Administration seems unlikely to review — at least in its current s…
Read guide →Dive Brief: Evommune, a biotechnology company making a pair of drugs for immune conditions such as chronic skin hives and atopic dermatitis, priced a $150 million initial public offering on Wednesday. The Palo…
Read guide →Dive Brief: Sarepta Therapeutics intends to seek full U.S. clearance for a pair of Duchenne muscular dystrophy medicines even though the two treatments failed a study designed to confirm the benefits observed …
Read guide →Dive Brief: Neok Bio emerged from stealth on Tuesday with $75 million in Series A funding and plans to develop what it claims are “differentiated” antibody-drug conjugates, or ADCs, that can overcome the limit…
Read guide →Peptide Niacinamide Vitamin C Peptide Niacinamide Vitamin C:A Researcher's Manual for Formulation Compatibility Enhanced buyer understanding of molecular stability now influences purchasing decisions within th…
Read guide →Today, a brief rundown of news from Intellia Therapeutics and the Food and Drug Administration, as well as updates from Eli Lilly, Gilead Sciences, Johnson & Johnson and Recursion Pharmaceuticals that you may …
Read guide →Today, a brief rundown of news from Metagenomi and Ovid Therapeutics, as well as updates from Cogent Biosciences, Galecto, AnaptysBio and Lyell Immunopharma that you may have missed. Metagenomi will lay off a …
Read guide →Browse by subject
Each topic opens a crawlable collection of related articles and resources.